The authors have no conflicts of interest to report.This study was presented at the European Society of Medical Decision Making. Erasmus MC Universitaire Medisch Centrum Rotterdam, Rotterdam, the Netherlands on June 7, 2004 and at the Society of General Internal Medicine, Chicago, IL on May 14, 2004.
BRIEF REPORT: Physicians and Their Personal Prostate Cancer-screening Practices with Prostate-specific Antigen
A National Survey
Version of Record online: 20 JAN 2006
Journal of General Internal Medicine
Volume 21, Issue 3, pages 257–259, March 2006
How to Cite
Chan, E. C.Y., Barry, M. J., Vernon, S. W. and Ahn, C. (2006), BRIEF REPORT: Physicians and Their Personal Prostate Cancer-screening Practices with Prostate-specific Antigen. Journal of General Internal Medicine, 21: 257–259. doi: 10.1111/j.1525-1497.2006.00327.x
- Issue online: 28 MAR 2006
- Version of Record online: 20 JAN 2006
- Manuscript received March 7, 2005 , Initial editorial decision April 5, 2005 , Final acceptance October 5, 2005
- 7American Cancer Society. Summary of American Cancer Society recommendations for the early detection of cancer in asymptomatic people. In: Cancer Facts and Figures 2001. Atlanta, GA: National Home Office, American Cancer Society Inc.; 2001: 35.
- 8American Academy of Family Physicians. Introduction to AAFP summary of policy recommendations for periodic health examination. Available at: http://www.aafp.org/policy/camp/apndx_fc.html. Accessed July 10, 2001.
- 9American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology. 2000;14: 267–72; 277–80.
- 10U.S. Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137: 915–6.
- 20Psychological benefits of prostate cancer screening: the role of reassurance. Health Expectations. 2002;5: 104–13., , , ,